Ultralife Statistics
Total Valuation
Ultralife has a market cap or net worth of $118.84 million. The enterprise value is $162.59 million.
| Market Cap | 118.84M |
| Enterprise Value | 162.59M |
Important Dates
The next estimated earnings date is Friday, November 7, 2025, before market open.
| Earnings Date | Nov 7, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Ultralife has 16.64 million shares outstanding. The number of shares has increased by 1.73% in one year.
| Current Share Class | 16.64M |
| Shares Outstanding | 16.64M |
| Shares Change (YoY) | +1.73% |
| Shares Change (QoQ) | -0.14% |
| Owned by Insiders (%) | 36.70% |
| Owned by Institutions (%) | 37.10% |
| Float | 10.54M |
Valuation Ratios
The trailing PE ratio is 37.15.
| PE Ratio | 37.15 |
| Forward PE | n/a |
| PS Ratio | 0.66 |
| Forward PS | 0.54 |
| PB Ratio | 0.86 |
| P/TBV Ratio | 1.72 |
| P/FCF Ratio | 8.55 |
| P/OCF Ratio | 6.95 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 12.58, with an EV/FCF ratio of 11.70.
| EV / Earnings | 50.87 |
| EV / Sales | 0.91 |
| EV / EBITDA | 12.58 |
| EV / EBIT | 20.37 |
| EV / FCF | 11.70 |
Financial Position
The company has a current ratio of 3.31, with a Debt / Equity ratio of 0.39.
| Current Ratio | 3.31 |
| Quick Ratio | 1.45 |
| Debt / Equity | 0.39 |
| Debt / EBITDA | 3.86 |
| Debt / FCF | 3.93 |
| Interest Coverage | 2.64 |
Financial Efficiency
Return on equity (ROE) is 2.40% and return on invested capital (ROIC) is 2.91%.
| Return on Equity (ROE) | 2.40% |
| Return on Assets (ROA) | 2.55% |
| Return on Invested Capital (ROIC) | 2.91% |
| Return on Capital Employed (ROCE) | 4.18% |
| Revenue Per Employee | $266,547 |
| Profits Per Employee | $4,763 |
| Employee Count | 671 |
| Asset Turnover | 0.92 |
| Inventory Turnover | 2.94 |
Taxes
In the past 12 months, Ultralife has paid $1.15 million in taxes.
| Income Tax | 1.15M |
| Effective Tax Rate | 26.00% |
Stock Price Statistics
The stock price has decreased by -24.92% in the last 52 weeks. The beta is 1.08, so Ultralife's price volatility has been similar to the market average.
| Beta (5Y) | 1.08 |
| 52-Week Price Change | -24.92% |
| 50-Day Moving Average | 7.52 |
| 200-Day Moving Average | 6.86 |
| Relative Strength Index (RSI) | 52.50 |
| Average Volume (20 Days) | 56,486 |
Short Selling Information
The latest short interest is 158,501, so 0.95% of the outstanding shares have been sold short.
| Short Interest | 158,501 |
| Short Previous Month | 163,822 |
| Short % of Shares Out | 0.95% |
| Short % of Float | 1.50% |
| Short Ratio (days to cover) | 2.43 |
Income Statement
In the last 12 months, Ultralife had revenue of $178.85 million and earned $3.20 million in profits. Earnings per share was $0.19.
| Revenue | 178.85M |
| Gross Profit | 43.71M |
| Operating Income | 7.98M |
| Pretax Income | 12.33M |
| Net Income | 3.20M |
| EBITDA | 12.93M |
| EBIT | 7.98M |
| Earnings Per Share (EPS) | $0.19 |
Balance Sheet
The company has $10.94 million in cash and $54.69 million in debt, giving a net cash position of -$43.75 million or -$2.63 per share.
| Cash & Cash Equivalents | 10.94M |
| Total Debt | 54.69M |
| Net Cash | -43.75M |
| Net Cash Per Share | -$2.63 |
| Equity (Book Value) | 138.65M |
| Book Value Per Share | 8.32 |
| Working Capital | 69.11M |
Cash Flow
In the last 12 months, operating cash flow was $17.10 million and capital expenditures -$3.20 million, giving a free cash flow of $13.90 million.
| Operating Cash Flow | 17.10M |
| Capital Expenditures | -3.20M |
| Free Cash Flow | 13.90M |
| FCF Per Share | $0.84 |
Margins
Gross margin is 24.44%, with operating and profit margins of 4.46% and 1.79%.
| Gross Margin | 24.44% |
| Operating Margin | 4.46% |
| Pretax Margin | 2.46% |
| Profit Margin | 1.79% |
| EBITDA Margin | 7.23% |
| EBIT Margin | 4.46% |
| FCF Margin | 7.77% |
Dividends & Yields
Ultralife does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.73% |
| Shareholder Yield | -1.73% |
| Earnings Yield | 2.69% |
| FCF Yield | 11.70% |
Analyst Forecast
The average price target for Ultralife is $14.00, which is 96.08% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $14.00 |
| Price Target Difference | 96.08% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Ultralife has an Altman Z-Score of 2.05 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.05 |
| Piotroski F-Score | 4 |